Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Perceptive Advisors Llc Insider Profile
109 Followers
Perceptive Advisors Llc, Ten Percent Owner at Amicus, holds 12.53M shares in Meiragtx Holdings (Ticker: MGTX), holds 5.36M shares in Acrivon Therapeutics, Inc. (Ticker: ACRV), holds 9.28M shares in Aldeyra Therapeutics (Ticker: ALDX). Most recently, Perceptive Advisors Llc Bought ― shares of Meiragtx Holdings on Aug 14, 2024 for an estimated value of 5.00M.
Profitable Transactions
85 out of 190 Profitable Transactions
Average Return
+20.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Perceptive Advisors Llc's holdings
Insider Roles
Roles that Perceptive Advisors Llc holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 06, 2023 - Jun 06, 2024
Return:+694.30%
The most profitable trade made by Perceptive Advisors Llc
Perceptive Advisors Llc's Trading History
Amicus
Oct 05, 2018
Ten Percent Owner
Informative Buy
629.70K
$196.88M
Aravive
Sep 25, 2017
―
Informative Sell
7.00M
$151.90K
Corium
Oct 15, 2018
―
Informative Sell
45.46M
$34.55M
Zogenix
Aug 14, 2018
―
Informative Buy
5.20M
$108.60M
Quotient
Nov 02, 2022
―
Informative Sell
660.45K
$309.86K
Global Blood Therapeutics
Dec 19, 2017
―
Informative Buy
6.65M
$334.85M
Albireo Pharma
Oct 13, 2022
―
Informative Sell
9.51M
$85.64M
Solid Biosciences
Jan 12, 2024
Director, Ten Percent Owner
Informative Buy
18.86M
$36.12M
La Jolla Pharma
Jan 09, 2019
―
Informative Sell
11.72M
$14.02M
Motus Gi Holdings
Jan 22, 2021
Ten Percent Owner
Informative Sell
2.53M
$87.80K
Dova Pharmaceuticals
Nov 15, 2019
―
Uninformative Sell
―
$0.00
Meiragtx Holdings
Aug 14, 2024
Director, Ten Percent Owner
Informative Buy
5.00M
$74.18M
Agile Therapeutics
Oct 15, 2021
―
Informative Buy
4.87M
$32.70M
Verrica Pharmaceuticals
Dec 29, 2023
Ten Percent Owner
Informative Buy
2.31M
$7.03M
Athenex
Sep 14, 2020
―
Informative Buy
22.05M
$202.99K
ADMA Biologics
Sep 30, 2021
Ten Percent Owner
Informative Sell
299.24K
$282.49M
Kadmon Holdings
Nov 18, 2019
―
Informative Buy
5.00M
$139.05M
Crinetics Pharmaceuticals
Apr 18, 2022
Ten Percent Owner
Informative Buy
3.50M
$303.46M
Lyra Therapeutics
Jun 02, 2023
Director, Ten Percent Owner
Informative Buy
8.99M
$2.31M
VYNE Therapeutics
Aug 18, 2021
Ten Percent Owner
Informative Sell
435.00K
$14.31M
Leap Therapeutics
Jun 24, 2020
Ten Percent Owner
Informative Buy
3.50M
$21.87M
Athira Pharma
Dec 29, 2023
Director, Ten Percent Owner
Informative Buy
1.46M
$3.56M
Cerevel Therapeutics Holdings
Feb 21, 2024
―
Uninformative Sell
―
$485.34M
Astria Therapeutics
Feb 05, 2024
Director
Informative Buy
30.00M
$60.57M
Landos Biopharma
Feb 09, 2021
―
Informative Buy
3.21M
$411.84M
Prometheus Biosciences
Mar 16, 2021
―
Informative Buy
16.15M
$662.54M
Rain Oncology
Oct 13, 2021
―
Informative Sell
667.48K
$3.01M
Nautilus Biotechnolgy
Dec 10, 2021
Director, Ten Percent Owner
Informative Buy
1.07M
$21.68M
IsoPlexis
Oct 14, 2021
―
Informative Buy
12.75M
$3.12M
LianBio Sponsored ADR
Feb 20, 2024
Director, Ten Percent Owner
Uninformative Buy
86.09K
$17.27M
Soleno Therapeutics
Sep 28, 2023
Ten Percent Owner
Informative Buy
15.11M
$167.96M
CARGO Therapeutics, Inc.
Nov 14, 2023
Former 10% Owner
Uninformative Buy
―
$5.24M
Acrivon Therapeutics, Inc.
Apr 15, 2024
Ten Percent Owner
Informative Buy
20.00M
$34.52M
Talphera
Jun 21, 2017
Ten Percent Owner
Informative Sell
2.10M
$4.19M
Aldeyra Therapeutics
Apr 08, 2024
Ten Percent Owner
Informative Buy
833.87K
$44.62M
VBI Vaccines
Apr 06, 2023
Ten Percent Owner
Informative Sell
1.48M
$414.41K
Heron Therapeutics
Jul 07, 2011
Ten Percent Owner
Informative Buy
―
$28.27M
Aegerion
Sep 09, 2013
―
Informative Buy
5.00M
$5.56M
Repros
Mar 19, 2013
―
Informative Sell
25.25M
$544.42K
Synageva
Nov 08, 2011
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Perceptive Advisors Llc's performance on stock
You May Also Like
Perceptive Advisors Llc insider profile FAQ
What is the percentage of profitable transactions made by Perceptive Advisors Llc?
The percentage of profitable transactions made by Perceptive Advisors Llc is 45%.
What is the average return per transaction made by Perceptive Advisors Llc?
The average return per transaction made by Perceptive Advisors Llc is 20.50%.
What stocks does Perceptive Advisors Llc hold?
Perceptive Advisors Llc holds: FOLD, ARAV, CORI, ZGNX, QTNTQ, GBT, ALBO, SLDB, LJPC, MOTS, DOVA, MGTX, AGRX, VRCA, ATNXQ, ADMA, KDMN, CRNX, LYRA, VYNE, LPTX, ATHA, CERE, ATXS, LABP, RXDX, RAIN, NAUT, ISO, LIANY, SLNO, CRGX, ACRV, TLPH, ALDX, VBIVQ, HRTX, AEGR, ~RPRX, GEVA stocks.
What was Perceptive Advisors Llc’s latest transaction?
Perceptive Advisors Llc latest transaction was an Informative Buy of $5.00M.
What was Perceptive Advisors Llc's most profitable transaction?
Perceptive Advisors Llc’s most profitable transaction was an Informative Buy of SLNO stock on June 6, 2023. The return on the trade was 694.30%.
What is Perceptive Advisors Llc's role in Amicus?
Perceptive Advisors Llc's role in Amicus is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.